Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selective and Potent PROTAC Degraders of c-Src Kinase.
Mao W, Vandecan NM, Bingham CR, Tsang PK, Ulintz P, Sexton R, Bochar DA, Merajver SD, Soellner MB. Mao W, et al. Among authors: soellner mb. ACS Chem Biol. 2024 Jan 19;19(1):110-116. doi: 10.1021/acschembio.3c00548. Epub 2023 Dec 19. ACS Chem Biol. 2024. PMID: 38113191
Development of a highly selective c-Src kinase inhibitor.
Brandvold KR, Steffey ME, Fox CC, Soellner MB. Brandvold KR, et al. Among authors: soellner mb. ACS Chem Biol. 2012 Aug 17;7(8):1393-8. doi: 10.1021/cb300172e. Epub 2012 Jun 4. ACS Chem Biol. 2012. PMID: 22594480 Free PMC article.
Development of a chimeric c-Src kinase and HDAC inhibitor.
Ko KS, Steffey ME, Brandvold KR, Soellner MB. Ko KS, et al. Among authors: soellner mb. ACS Med Chem Lett. 2013 Aug 8;4(8):779-783. doi: 10.1021/ml400175d. ACS Med Chem Lett. 2013. PMID: 24015327 Free PMC article.
Exquisitely specific bisubstrate inhibitors of c-Src kinase.
Brandvold KR, Santos SM, Breen ME, Lachacz EJ, Steffey ME, Soellner MB. Brandvold KR, et al. Among authors: soellner mb. ACS Chem Biol. 2015 Jun 19;10(6):1387-91. doi: 10.1021/cb501048b. Epub 2015 Mar 31. ACS Chem Biol. 2015. PMID: 25793938 Free PMC article.
UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer.
Gilani RA, Phadke S, Bao LW, Lachacz EJ, Dziubinski ML, Brandvold KR, Steffey ME, Kwarcinski FE, Graveel CR, Kidwell KM, Merajver SD, Soellner MB. Gilani RA, et al. Among authors: soellner mb. Clin Cancer Res. 2016 Oct 15;22(20):5087-5096. doi: 10.1158/1078-0432.CCR-15-2158. Epub 2016 May 6. Clin Cancer Res. 2016. Retraction in: Clin Cancer Res. 2020 Apr 1;26(7):1777. doi: 10.1158/1078-0432.CCR-20-0653 PMID: 27154914 Retracted.
51 results